Published in Cancer Weekly, September 19th, 2006
The patent application is based on the results of recent experiments published in the journal Clinical Cancer Research by the inventors, CytoGenix' chief scientific officer, Dr. Yin Chen, and CytoGenix director and scientific advisor, Dr. Cy A. Stein, professor of medicine at Albert Einstein College of Medicine and Montefiore Medical Center. These experiments show that the company's proprietary ssDNA technology effectively combats some types of tumor growth and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.